CXCL12 and Sepsis: It was also reported that stromal cell-derived factor-1 (SDF-1)-pretreated ERCs exerted therapeutic effects by alleviating sepsis-related symptoms, reducing tissue damage, modulating inflammatory imbalance, and alleviating oxidative stress in a mouse model of sepsis.